Described herein are compositions of pyrvinium salts suitable for oral administration. These compositions are in the form of solutions and demonstrate bioavailability both in blood plasma and in pancreatic tissue. Also described herein are methods of treating, ameliorating, and/or preventing pancreatic cancer, including orally administering a composition comprising pyrvinium pamoate.

Cannabinoids composition with desirable bioavailability of cannabinoids are provided. In some embodiments, the cannabinoid compositions are modular, and thus, they can be divided into smaller portions so that a user may decide precisely how much they will use. In some embodiments, the cannabinoid compositions can be partially or entirely crushed or chewed by the user as a means of increasing the rate of absorption.

Cannabinoids composition with desirable bioavailability of cannabinoids are provided. In some embodiments, the cannabinoid compositions are modular, and thus, they can be divided into smaller portions so that a user may decide precisely how much they will use. In some embodiments, the cannabinoid compositions can be partially or entirely crushed or chewed by the user as a means of increasing the rate of absorption.

The present invention generally relates to oral strips containing one or more active agents and methods of making oral strips containing an active agent. When the strip is placed in the mouth of a user, the active agent(s) is/are delivered to the user by way of oral mucosa.

The present invention generally relates to oral strips containing one or more active agents and methods of making oral strips containing an active agent. When the strip is placed in the mouth of a user, the active agent(s) is/are delivered to the user by way of oral mucosa.

The present disclosure provides pharmaceutical compositions comprising mometasone and diisopropyl adipate (DIPA) for topical administration. These compositions can be formulated as creams, lotions, and foams, and are particularly suitable for administration in hairy skin; for example, for treating inflammatory skin conditions, such as dermatitis, eczema, and psoriasis.

The present disclosure provides pharmaceutical compositions comprising mometasone and diisopropyl adipate (DIPA) for topical administration. These compositions can be formulated as creams, lotions, and foams, and are particularly suitable for administration in hairy skin; for example, for treating inflammatory skin conditions, such as dermatitis, eczema, and psoriasis.

A method for forming a cannabis-based topical remedy includes adding cannabis to an oil. The method further includes heating the mixture of the cannabis and the oil for a first period of time. The method further includes adding a wax to the heated mixture. The method further includes packaging a resulting mixture.

A method for forming a cannabis-based topical remedy includes adding cannabis to an oil. The method further includes heating the mixture of the cannabis and the oil for a first period of time. The method further includes adding a wax to the heated mixture. The method further includes packaging a resulting mixture.

A product and process of manufacturing an edible soft-chewable dosage form for the delivery of pharmaceutically active ingredients or nutritional agents orally to an animal or human subject, by forming a granulated soft-chew mass by appropriate mixing and sifting steps, and forming tablets with a compression press. Such soft-chew dosage forms have hardness of less than about two kilopond (2 kp) and friability of less than about one percent (1%) at three-hundred (300) rotations when measured according to the United States Pharmacopeia (USP) test. The process for manufacturing such compressed soft-chew tablets employs compression (tablet) pressing equipment to produce soft-chew tablets of consistent weight and texture.